Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration (Myridian)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by The Nazareth Hospital, Israel.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Western Galilee Hospital-Nahariya
Information provided by (Responsible Party):
The Nazareth Hospital, The Nazareth Hospital, Israel
ClinicalTrials.gov Identifier:
NCT01566006
First received: November 15, 2010
Last updated: March 28, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)